# Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)

> **NCT00828477** · PHASE4 · COMPLETED · sponsor: **Bp Consulting, Inc** · enrollment: 25 (estimated)

## Conditions studied

- Intraocular Pressure

## Interventions

- **DRUG:** Xibrom
- **DRUG:** Nevanac

## Key facts

- **NCT ID:** NCT00828477
- **Lead sponsor:** Bp Consulting, Inc
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2009-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00828477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00828477, "Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00828477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*